A free open-access webinar will introduce the Cancer Genome Interpreter (CGI), an advanced bioinformatics tool to interpret mutations in cancer genomes developed by IRB Barcelona and co-created with ...
BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced an oral presentation at the United States and Canadian Academy of Pathology (USCAP) 115th Annual ...
Researchers at Inocras, a bioinformatics-led precision health company harnessing the power of whole-genome sequencing (WGS) ...
Cancer’s strongest gene switches push DNA into damaging overdrive, creating repeated breaks and repairs that may fuel tumor ...
In a single experiment, scientists can decipher the entire genomes of many patient samples, animal models, or cultured cells.
UC San Francisco Chancellor emeritus J. Michael Bishop, MD, a pioneering microbiologist who shared the 1989 Nobel Prize in ...
In 2022, NIST started the Cancer Genome in a Bottle program as part of a major partnership between government, universities and industry to focus on fighting cancer. Specifically, the goal of the ...
Inocras, a bioinformatics-led company harnessing the power of whole genome data and proprietary analytics to deliver curated insights, today announced a strategic partnership with NDS Corporation (NDS ...
The future of precision medicine will depend less on choosing between genomics or real-world evidence and more on how ...
A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer ...
Scientists have mapped the genetics of cancer in cats for the first time at scale, uncovering major overlaps with human ...
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results